| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ddbeb7a5705bf2f6de81ed96620e637
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dbb6628870fd91e40081ffa56023618f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6184a5846496e3fae4c5ba86cddc4cd5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4b5be8da8252280fab2cab5208010bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5457e146b022e031c6bd6db6e7bbd883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e1120710706a835896ce34eebd78390
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18f50550bd24c5dc4d7a7c400dedd442 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-00 |
| filingDate |
2016-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9c6b6e7d53b155fe21ffad8bdaef482
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36ad4f99d5a6ab6db9c6b86451d26a38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfff318bd17565e6e26b9d18bb926b3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35c616f56e4fb54e12877d21756df492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae1fbd037ecaa7d24a0d9028f3205a07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0b77a2144450f5e9adaefd8f141a1b5 |
| publicationDate |
2018-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3262039-A2 |
| titleOfInvention |
Process for the preparation of amorphous (1s)-1,5-anhvdro-1-[3-[[5-(4 fluorophennyl)-2-thienyl]methvl]-4-methylphenyl]-d-glucitol and its polymorphs thereof |
| abstract |
The present invention relates to an improved process for the preparation of amorphous (lS)-l,5-anhydro-l -[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol compound of formula- 1, represented by the following structural formula: |
| priorityDate |
2015-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |